Medpage Today on MSN
Tardive Dyskinesia's Impact on Quality of Life
Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like ...
Learn about tardive dyskinesia symptoms, causes, diagnosis, treatment options, and chances of remission with expert guidance and timely intervention.
Accurate and early diagnosis of tardive dyskinesia (TD), a serious movement disorder typically caused by exposure to antipsychotic medications, is imperative for long-term management. "Keeping an eye ...
Some studies suggest vitamin E may help ease symptoms of tardive dyskinesia — but how strong is the evidence, and what does it really tell us? Note: The U.S. Food and Drug Administration (FDA) does ...
Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...
As with anything in medicine, there are areas of unmet need. And when it comes to tardive dyskinesia, I'm thinking about care gaps. And the first care gap that comes to mind is that the routine use of ...
The KINECT-PRO™ analysis is the first and only of its kind to report both remission of tardive dyskinesia symptoms and associated improvements in patient-reported outcomes. Post-hoc analysis from ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has confirmed its initial recommendation to not consider deutetrabenazine as a new active substance. In June this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results